Duquesne Family Office's 15 New Stock Picks
An imminent collapse and recession was the sentiment echoed by billionaire Stanley Druckenmiller late last year in response to an aggressive monetary policy tightening.
Source: insidermonkey.com
Page 41 - Recursion Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Recursion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Recursion Pharmaceuticals Today - Breaking & Trending Today
Allspring Global Investments Holdings LLC Acquires 6,615 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Allspring Global Investments Holdings LLC boosted its holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 453.7% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 8,073 shares of the company’s stock after purchasing an additional 6,615 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Recursion Pharmaceuticals were worth $60,000 […]
Source: defenseworld.net
2 Risky Stocks With Massive Potential | The Motley Fool
Neither is doing well this year.
Source: fool.com
Michael Secora Sells 25,000 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CFO Michael Secora sold 25,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 10th. The stock was sold at an average price of $7.07, for a total transaction of $176,750.00. Following the sale, the chief financial officer now owns 900,686 shares in […]
Source: modernreaders.com
Insider Sell: CFO Michael Secora Sells 50,000 Shares of Recursion Pharmaceuticals Inc (RXRX)
On October 11, 2023, Michael Secora, the Chief Financial Officer (CFO) of Recursion Pharmaceuticals Inc (NASDAQ:RXRX), sold 50,000 shares of the company.
Source: yahoo.com